MECHANISMS OF CLINICAL DRUG RESISTANCE TO ALKYLATING AGENTS

This publication has 26 references indexed in Scilit:

• 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review
  Advances in Cancer Research, 1973
• Immunochemotherapy of Cancer with Chlorambucil-carrying Antibody
  BMJ, 1972
• 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanoma
  Published by Elsevier ,1972
• Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds
  Nature, 1972
• Syntheses and Biological Activity of 5-Aminoimidazoles and 5-Triazenoimidazoles
  Journal of Pharmaceutical Sciences, 1970
• CIS-dichlorodiammineplatinum (II)
  Biochemical Pharmacology, 1970
• Reduction of the toxicity of “radiomimetic” alkylating agents by thiol pretreatment—VI
  Biochemical Pharmacology, 1967
• Clinical Pharmacology of the Effective Antitumor Drugs
  Annual Review of Pharmacology, 1965
• The effect of glucose pretreatment on the anti-tumour action of Mannitol Myleran
  Biochemical Pharmacology, 1964
• THE ROLE OF ADSORPTION IN CONTROLLING THE RATE OF REACTION OF CHLORAMBUCIL WITH PROTEIN
  Canadian Journal of Biochemistry and Physiology, 1963